1
TITLE: AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma
AUTHORS: Leonard, JP; Trneny, M; Izutsu, K; Fowler, NH; Hong, X; Zhu, J; Zhang, H; Offner, F; Scheliga, A; Nowakowski, GS; Pinto, A; Re, F; Fogliatto, LM; Scheinberg, P; Flinn, IW; Moreira, C; Cabeçadas, J; Liu, D; Kalambakas, S; Fustier, P; Wu, C; Gribben, JG; ...More
PUBLISHED: 2019, SOURCE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, ISSUE: 14
INDEXED IN: Scopus WOS